[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
This episode provides numerous actionable protocols, most of which are zero-to-low cost, for improving skin health and appearance, reducing cancer risk, and treating skin problems
doi: 10.1016/j.neuropharm.2023.109716 [DOI] [PubMed] [Google Scholar] 78.Chen X, Ma L, Gan K, et al
For those who remain needle-phobic, 2026 has seen an increase in the availability of semaglutide tablets
Both responses are normal
You may also experience more stomach-related side effects like nausea or diarrhoea